线粒体DNA突变与高血压
Mutations in Mitochondrial DNA and Hypertension
DOI: 10.12677/acm.2012.21001, PDF, HTML, XML,    科研立项经费支持
作者: 秦文蓓, 张富春, 郑秀芬：新疆大学生命科学与技术学院分子生物学实验室
关键词: 高血压；线粒体DNA；突变；母系遗传
Hypertension; Mitochondrial DNA; Mutation; Maternal Inheritance
摘要: 高血压是当今社会最常见的心血管疾病，是导致死亡的主要危险因素之一。线粒体DNA的突变会导致线粒体代谢缺陷，影响蛋白质合成，氧化磷酸化功能受损，减少ATP的合成，增加了活性氧的产生。因此，线粒体DNA突变是线粒体疾病的研究热点之一。高血压相关的线粒体DNA突变的深入研究有助于进一步理解母系遗传高血压的分子致病机制，为高血压的控制和治疗提供理论依据。文章对高血压相关的线粒体DNA突变进行了综述。
Abstract: Hypertension is one of the most common cardiovascular disease. It is one of the main risk factors associated with cardiovascular death. Mutations in mitochondrial DNA lead to failures in metabolism, affecting mitochondrial protein synthesis and oxidative phosphorylation function. These mutations result in a deficit in ATP synthesis and an increase of generation of reactive oxygen species. As a result, mitochondrial DNA mutation has been the highlight in this filed. These findings will be helpful for understanding the molecular mechanism of maternally inherited hypertension. It may provide new insights into management and treatment of maternally inherited hypertension. This review summarized the association between mtDNA mutations and hypertension.
文章引用：秦文蓓, 张富春, 郑秀芬. 线粒体DNA突变与高血压[J]. 临床医学进展, 2012, 2(1): 1-5. http://dx.doi.org/10.12677/acm.2012.21001

参考文献

[1] J. A. Whitwort. World organization, international society of hypertension writing group. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH). Journal of Hypertension, 2003, 21(11): 432.
[2] A. P. Brandao, A. A. Brandao, E. M. Araujo, et al. Familial aggregation of arterial blood pressure and possible genetic influence. Hypertension, 1992, 19(2): II214-II217.
[3] R. M. Fuentes, I. L. Notkola, S. Shemeikka, et al. Familial aggregation of blood pressure: A population-based family study in eastern Finland. Journal of Human Hypertension, 2000, 14(7): 441-445.
[4] E. A. Schon, E. Bonilla and S. Dimauro. Mitochondrial DNA mutations and pathogenesis. Journal of Bioenergetics Biomembranes, 1997, 29(2): 131-149.
[5] J. St John, D. Sakkas, K. Dimitriadi, et al. Failure of elimination of paternal mitochondrial DNA in abnormal embryos. Lancet, 2000, 355(9199): 200.
[6] D. C. Wallace. Mitochondrial disease in man and mouse. Science, 1999, 283(5407): 1482-1488.
[7] D. C. Wallace. Mitochondrial DNA variation in human evolution, degenerative disease, and aging. American Journal of Human Genetics, 1995, 57: 201-223.
[8] J. P. Jenuth, A. C. Peterson, K. Fu and E. A. Shoubridge. Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nature Genetics, 1996, 14(2): 146-151.
[9] 严庆丰, 管敏鑫. 线粒体疾病与核基因—线粒体基因的表达调控[J]. 生命科学, 2008, 20(4): 496-505.
[10] A. F. Dominiczak, D. C. Negrin, J. S. Clark, et al. Genes and hypertension: From gene mapping in experimental models to vascular gene transfer strategies. Hypertension, 2000, 35: 164- 172.
[11] X. Li, M. X. Guan. A human mitochondrial GTP binding protein related to tRNA Modification may modulate the phenotypic expression of the deafness-associated mitochondrial 12S rRNA mutation. Molecular Cell Biology, 2002, 22(21): 7701-7711.
[12] 朱海燕. 高血压病及其靶器官损害的临床、分子生物学及遗传学研究[D]. 中国人民解放军军医进修学院, 2008.
[13] H. Y. Zhu, S. W. Wang, L. J. Martin, et al. The role of mitochondrial genome in essential hypertension in a Chinese Han population. European Journal of Human Genetics, 2009, 17(11), 1501- 1506.
[14] S. W. Wang, R. H. Li, A. Fettermann, et al. Maternally inherited essential hypertension is associated with the novel 4263A > G mutation in the mitochondrial tRNAIle gene in a large Han Chinese Family. Circulation Research, 2011, 108: 862-870.
[15] Z. B. Li, Y. H. Liu, R. Chen, et al. Mitochondrial tRNAMet mutation in Chinese Han essential hypertensive individuals. Hereditas, 2011, 33(9): 601-606.
[16] Z. Q. Lu, H. Chen, Y. Z. Meng, et al. Hypertension in a Chinese pedigree. European Journal of Human Genetics, 2011, 19(11): 1181-1186.
[17] Z. B. Li, Y. Q. Liu, Y. Li, et al. Maternally inherited hypertension is associated with the mitochondrial tRNAIle A4295G mutation in a Chinese family. Biochemical and Biophysical Research Communication, 2008, 367(4): 906-911.
[18] L. Xue, H. Chen, Y. Z. Meng, et al. Mutations in mitochondrial DNA associated with hypertension. Hereditas, 2011, 33(9): 911- 918.
[19] F. H. Wilson, A. Hariri, A. Farhi, et al. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science, 2004, 306(5699): 1190-1194.
[20] B. Watson, M. A. Khan, R. A. Desmond, et al. Mitochondrial DNA mutations in black Americans with hypertension-asso- coated end-stage renal disease. American Journal of Kidney Dis- eases, 2001, 38(3): 529-536.
[21] F. Schwartz, A. Duka, F. Sun, et al. Mitochondrial genome mutations in hypertensive individuals. American Journal of Hypertens, 2004, 17(7): 629-635.
[22] S. A. Austin, F. J. Vriesendrop, F. T. Thandroyen, et al. Expanding the phenotype of the 8344 transfer RNA lysine mitochondrial DNA mutation. Neurology, 1998, 51(5): 1447-1450.
[23] M. Shoji, S. Tsutaya, T. Kasai and M. Yasujima. Implication of single nucleotide polymorphisms in association study: Mitochondrial variations as another genetic markers for hypertension. Rinsho Byori, 2002, 50(5): 497-501.
[24] L. L. Liu, D. J. Tan, B. Xu, et al. Study on the genetic mechanism of essential hypertension: Scanning analysis of the entire mitochondrial gene variations. Chinese Journal of Clinical Rehabilitation, 2004, 8(12): 2271-2274.
[25] R. H. Li, Y. Q. Liu, Z. B. Li, et al. Failures in mitochondrial tRNAMet and tRNAGln metabolism caused by the novel 4401A > G mutation are involved in essential hypertension in a Han Chinese family. Hypertension, 2009, 54(2): 329-337.

为你推荐